U.S. stock pre-market QLGN rose over 330%, having previously received a $41 million investment from Faraday Future and transformed into an encryption company.

On September 22, according to market data, Qualigen Therapeutics (QLGN) rose 333.8% in pre-market trading, currently reporting at $12.32. Previously reported, on September 20, Faraday Future (NASDAQ: FFAI) announced a strategic investment in Qualigen Therapeutics(NASDAQ: QLGN) through a $41 million PIPE deal, the latter of which will be renamed CXC10 and transition to an encryption and Web3 business platform.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)